We are live on
!
Find out more
AC
Armistice Capital Portfolio holdings
AUM
$5.62B
1-Year Est. Return
36.06%
This Fund
S&P 500
This Quarter
Est. Return
+13.99%
1 Year Est. Return
+36.06%
3 Year Est. Return
+44.14%
5 Year Est. Return
+38.37%
10 Year Est. Return
+188.88%
AUM
$7.33B
AUM Growth
+$796M
(+12%)
Cap. Flow
-$12M
Cap. Flow
% of AUM
-0.16%
Top 10 Holdings %
Top 10 Hldgs %
60.07%
Holding
377
New
123
Increased
61
Reduced
77
Closed
82
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
GSK
GSK
|
+$68.6M |
| 2 |
argenx
ARGX
|
+$55M |
| 3 |
Sanofi
SNY
|
+$50.7M |
| 4 |
SWAV
Shockwave Medical, Inc. Common Stock
SWAV
|
+$50.5M |
| 5 |
Jazz Pharmaceuticals
JAZZ
|
+$42.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
|
+$48.6M |
| 2 |
Keurig Dr Pepper
KDP
|
+$45.5M |
| 3 |
Incyte
INCY
|
+$45.2M |
| 4 |
UnitedHealth
UNH
|
+$37.3M |
| 5 |
Campbell Soup
CPB
|
+$32M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 34.97% |
| 2 | Consumer Staples | 5.35% |
| 3 | Consumer Discretionary | 4.92% |
| 4 | Technology | 3.86% |
| 5 | Communication Services | 1.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
Live Nation Entertainment
LYV
$42.8B
| $8.28M | 0.11% |
88,440
-59,648
| -40% | -$5.13M |
|
102
Coupang
CPNG
$28.7B
| $8.1M | 0.11% |
+500,000
| New | +$8.25M |
|
103
Performance Food Group
PFGC
$17.6B
| $8.06M | 0.11% |
+116,616
| New | +$7.17M |
|
104
Aquestive Therapeutics
AQST
$471M
| $7.93M | 0.11% |
3,924,000
-876,000
| -18% | -$1.55M |
|
105
Inspire Medical Systems
INSP
$1.73B
| $7.43M | 0.1% |
36,522
+32,899
| +908% | +$5.33M |
|
|
FREE
106
DELISTED
Whole Earth Brands, Inc. Class A Common Stock
FREE
| $7.33M | 0.1% |
2,150,000
| – | – |
|
|
SDIG
107
DELISTED
Stronghold Digital Mining, Inc. Class A Common Stock
SDIG
| $7.3M | 0.1% |
+1,000,000
| New | +$4.91M |
|
108
Best Buy
BBY
$17.8B
| $7.2M | 0.1% |
+92,000
| New | +$6.48M |
|
109
Geron
GERN
$1.05B
| $6.95M | 0.09% |
3,296,000
-328,000
| -9% | -$638K |
|
110
Ulta Beauty
ULTA
$23.2B
| $6.71M | 0.09% |
13,700
+12,396
| +951% | +$5.23M |
|
111
TSMC
TSM
$2.15T
| $6.66M | 0.09% |
64,000
-24,000
| -27% | -$2.29M |
|
112
Ryman Hospitality Properties
RHP
$8.05B
| $6.6M | 0.09% |
+60,000
| New | +$5.72M |
|
|
SPRB
113
Spruce Biosciences
SPRB
$128M
| $6.53M | 0.09% |
29,733
-11,014
| -27% | -$1.27M |
|
114
AngioDynamics
ANGO
$622M
| $6.27M | 0.09% |
+800,000
| New | +$5.55M |
|
|
ASRT
115
DELISTED
Assertio
ASRT
| $6.21M | 0.08% |
386,667
+125,067
| +48% | +$3.09M |
|
116
UiPath
PATH
$7.16B
| $5.86M | 0.08% |
236,000
-336,189
| -59% | -$6.56M |
|
117
Herbalife
HLF
$1.31B
| $5.8M | 0.08% |
+380,000
| New | +$5.25M |
|
|
GB
118
DELISTED
Global Blue Group Holding
GB
| $5.74M | 0.08% |
1,214,475
+14,600
| +1% | +$73.3K |
|
|
LYRA
119
DELISTED
LYRA THERAPEUTICS INC
LYRA
| $5.7M | 0.08% |
21,760
-9,240
| -30% | -$1.67M |
|
|
CKPT
120
DELISTED
Checkpoint Therapeutics
CKPT
| $5.56M | 0.08% |
2,426,000
+362,000
| +18% | +$788K |
|
121
M&T Bank
MTB
$36.5B
| $5.48M | 0.07% |
40,000
| – | – |
|
122
Churchill Downs
CHDN
$6.02B
| $5.4M | 0.07% |
+40,000
| New | +$4.75M |
|
123
10x Genomics
TXG
$6.03B
| $5.15M | 0.07% |
+92,000
| New | +$4M |
|
124
On Holding
ONON
$12.7B
| $5M | 0.07% |
+185,458
| New | +$5.05M |
|
125
O'Reilly Automotive
ORLY
$76.3B
| $4.75M | 0.06% |
+75,000
| New | +$4.74M |
|
Similar funds
CRC
RMDI
F
EW
O
DSC
ACM
PI
Armistice Capital's Q4 2023 Portfolio in Review
As of Q4 2023, Armistice Capital held 377 positions worth $7.33B, up 12% from $6.53B the previous quarter. Its ten largest holdings account for 60% of the portfolio.
Armistice Capital's Q4 2023 filing shows 123 new, 61 increased, 77 reduced and 82 closed positions. Its largest new stake was Sanofi: 1,036,000 shares worth $51.5M. The largest sale was Mirati Therapeutics, Inc. Common Stock, an estimated $48.6M.
By sector, the portfolio is most concentrated in Healthcare at 35% of assets, up from 34% a quarter earlier, followed by Consumer Staples and Consumer Discretionary.
- Armistice Capital's largest Q4 2023 buy was Sanofi: 1,036,000 shares worth $51.5M.
- Armistice Capital added most to GSK in Q4 2023, an estimated $68.6M increase.
- Armistice Capital's biggest Q4 2023 reduction was Mirati Therapeutics, Inc. Common Stock, cutting an estimated $48.6M.
- Armistice Capital fully exited Keurig Dr Pepper in Q4 2023, selling an estimated $45.5M.
- Armistice Capital's ten largest holdings make up 60% of its $7.33B portfolio in Q4 2023.
- Armistice Capital opened 123 new positions and closed 82 in Q4 2023.
- Armistice Capital's portfolio value rose 12% quarter-over-quarter to $7.33B.
Based on Armistice Capital's 13F filing for Q4 2023, filed 13 Feb 2024.